John B. Replogle - 11 Nov 2025 Form 4 Insider Report for Crocs, Inc. (CROX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Nov 2025, 17:05:25 UTC
Prior SEC filing
19 Aug 2025
Next SEC filing
18 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Sara Hoverstock, Attorney-in-Fact

Key filing fact

John B. Replogle filed Form 4 for Crocs, Inc. (CROX) on 12 Nov 2025.

Key facts

  • This page summarizes John B. Replogle's Form 4 filing for Crocs, Inc. (CROX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2025, 17:05.

Change

  • Previous filing in this sequence was filed on 19 Aug 2025.
  • Current net transaction value: +$223,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001503546 Primary reporting owner

REPLOGLE JOHN B

Relationship
Director
Address
C/O CROCS, INC., 500 ELDORADO BLVD #5, BROOMFIELD
Signature
/s/Sara Hoverstock, Attorney-in-Fact
Signature date
12 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CROX transaction

Common Stock

Purchase

Transaction value
$223,500
Shares
+3,000
Change %
+19%
Price
$74.50
Shares after
18,417
Date
11 Nov 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .